Stock Scorecard



Stock Summary for XOMA Corp (XOMAP)

Total Score

19 out of 29

Currently on the following lists
Dividend Stock List
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for XOMAP

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for XOMAP

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for XOMAP

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for XOMAP

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Financial Details for XOMAP

Company Overview

Company Name XOMA Corp
Country USA
Description XOMA Corporation, a biotech royalty aggregator, discovers and develops therapeutic candidates in the United States, Europe, and Asia Pacific. The company is headquartered in Emeryville, California.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2022
Next Earnings Date

Stock Price History

Last Day Price 24.48
Last Day Volume 6,596
Average Daily Volume 1,826
52-Week High 26.01
52-Week Low 22.14
Last Price to 52 Week Low 10.57 %

Valuation Measures

Trailing PE 24.46
Industry PE 36.99
Sector PE 93.21
5-Year Average PE 62.04
Free Cash Flow Ratio 0.00
Industry Free Cash Flow Ratio 8.14
Sector Free Cash Flow Ratio 37.54
Book Value Per Share Most Recent Quarter 11.38
Price to Book Ratio 0.00
Industry Price to Book Ratio 6.06
Sector Price to Book Ratio 15.42
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 66.70
Sector Price to Sales Ratio Twelve Trailing Months 25.17

Share Statistics

Total Shares Outstanding 0
Market Capitalization 0
Institutional Ownership 0.00 %

Dividends

Ex-Dividend Date 9/30/2022
Last Dividend Amount 0.54
Current Dividend Amount 0.54
Dividend Aristocrat? False
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00 %
Trailing Annual Dividend Rate 2.14
Trailing Annual Dividend Yield 9.00 %
5-Year Average Dividend Yield 0.00 %
5-Year Dividend Payments Count 7
Dividend Payout Ratio 0.00 %

Income Statement

Quarterly Earnings Growth YOY 37.00 %
Annual Earnings Growth 18.80 %
Reported EPS Past Year -1.33
Reported EPS Prior Year 0.17
Net Income Twelve Trailing Months 18,716,000
Net Income Past Year 15,798,000
Net Income Prior Year 13,298,000
Quarterly Revenue Growth YOY -52.00 %
5-Year Revenue Growth -7.75 %

Balance Sheet

Total Cash Per Share 0.00
Total Cash Most Recent Quarter 78,743,000
Total Cash Past Year 94,102,000
Total Cash Prior Year 84,222,000
Net Cash Position Most Recent Quarter 78,743,000
Net Cash Position Past Year 73,250,000
Long Term Debt Past Year 20,852,000
Long Term Debt Prior Year 20,852,000
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 0.87
Equity to Debt Ratio Most Recent Quarter 1.00
Current Ratio Most Recent Quarter 14.70
Total Stockholder Equity Past Year 141,876,000
Total Stockholder Equity Prior Year 86,424,000
Total Stockholder Equity Most Recent Quarter 130,325,000

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

MACD 0.18
MACD Signal 0.04
20-Day Bollinger Lower Band 22.18
20-Day Bollinger Middle Band 24.29
20-Day Bollinger Upper Band 26.39
Beta 0.82
RSI 67.13
50-Day SMA 24.38
200-Day SMA 0.00

System

Modified 11/27/2022 8:20:49 AM